Filing Details
- Accession Number:
- 0001209191-19-024035
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-04-08 18:26:10
- Reporting Period:
- 2019-04-08
- Accepted Time:
- 2019-04-08 18:26:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1227636 | Neuronetics Inc. | STIM | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1744956 | Christopher Thatcher | C/O Neuronetics, Inc. 3222 Phoenixville Pike Malvern PA 19355 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-04-08 | 15,000 | $0.87 | 69,811 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-04-08 | 15,000 | $16.82 | 54,811 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2019-04-08 | 15,000 | $0.00 | 15,000 | $0.87 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 375,297 | 2025-02-18 | No | 4 | M | Direct |
Footnotes
- These shares were sold in compliance with a trading plan adopted by the reporting person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.545 to$16.955 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities andExchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth inthis footnote to this Form 4.
- Ten percent (10%) of the shares subject to the option vested on February 19, 2015, Twenty-five percent (25%) of the shares subject to the option vested on November 1, 2015, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.
Billionaire Hedge Funds
